Human adenoviruses (HAdVs) are common pathogens associated with a variety of clinical manifestations. Although most infections are self-limiting, HAdVs can cause severe or lethal infections in immunocompromised as well as in healthy individuals. Several HAdVs have recently been characterized as emerging pathogens. In Italy, epidemiological, and especially molecular epidemiological, information on this pathogen is scarce. This study describes the characterization by cell culture, PCR and phylogenetic analysis of HAdV strains originating from a small collection of clinical samples gathered between 2008 and 2009. The distribution of different HAdV species was studied and the possible presence of newly emerging types was ascertained. A broad-range primer pair was used, targeting a portion of the hexon gene, in combination with species-specific primer pairs targeting a portion of the fiber gene. Human and animal reference AdV strains were included in the study. The broad-range assay identified all HAdV strains (study and reference samples), as well as three out of four animal AdV reference strains. Seven different types belonging to three HAdV species (B, C and F) were identified in the study samples. Species C was by far the most frequent. Two co-infections were detected, each with two serotypes within species C (types 1/2 and 2/6). The combined use of these two PCR assays -allowing not only the identification of known types but also, potentially, the discovery of newly emerging ones -can provide valuable epidemiological information on the spread of HAdVs.
INTRODUCTION
Human adenoviruses (HAdVs) are non-enveloped, icosahedral viruses of the genus Mastadenovirus, family Adenoviridae. These viruses have a linear, dsDNA genome (26-45 kb) encapsidated in an icosahedral protein shell (Benkö et al., 2005; Harrach & Benko, 2007) . There are 51 serotypes classified into six species, A-F, defined using biological characteristics, and four additional types, characterized using genomics and bioinformatics (Ishiko & Aoki, 2009; Ishiko et al., 2008; Jones et al., 2007; Walsh et al., 2009 Walsh et al., , 2010 . The 52nd type, described in 2007, was named HAdV-52 and accepted by the ICTV as the first member of the seventh species (G species).
Clinical manifestations are highly heterogeneous, ranging from upper and lower respiratory tract infections to gastroenteritis, pneumonia, urinary tract infection, conjunctivitis, hepatitis, myocarditis and encephalitis (Mena & Gerba, 2009; Russell, 2009) . HAdVs often cause mild, selflimiting disease, but may cause severe or life-threatening illness, particularly in immunocompromised patients, children and the elderly. Severe clinical presentations include haemorrhagic cystitis, enteritis, encephalitis and pneumonia (Adeyemi et al., 2008; Echavarria, 2008; Hoffman, 2009; Pham et al., 2003) . establishment of specific surveillance programmes, such as the National Surveillance for Emerging Adenovirus Infections in the USA (http://www.public-health.uiowa. edu/adv/), with the aim of investigating the current distribution of serotypes among different populations and the adenoviral types associated with severe clinical disease (i.e. resulting in hospitalization or death). In Italy, no nationwide surveillance system exists, and epidemiological data on HAdV infections is limited. During the winters of [2004] [2005] [2006] [2007] , an observational study with the objective of identifying the viruses responsible for influenza-like illness in Italy was performed (Puzelli et al., 2009) . Influenza virus was the most commonly identified agent, followed by HAdV. Cases attributable to other viruses were sporadic. Similarly, a clinical study of viral respiratory tract infections in Italian children conducted in 2006-2007 found HAdV to be the third most common virus (Fabbiani et al., 2009) . Another study (Carraturo et al., 2008) confirmed enteric HAdVs as important aetiological agents of diarrhoea in hospitalized children in Italy, after rotaviruses. These studies all indicate a wide circulation of HAdV in the Italian population. Information on the serotypes involved, however, is lacking.
In 2006, we published a study on HAdV typing in clinical samples collected between 1987 (La Rosa et al., 2006 . This study, involving phylogenetic analysis of a portion of the hexon gene, showed type 2 as the most common HAdV, followed by types 1 and 41. The present study sought to contribute to the body of knowledge available on the types responsible for AdV-related hospitalization in Italy and on the molecular epidemiology of HAdV infections. We performed phylogenetic analyses on AdV sequences originating from a collection of clinical samples including both the sequences obtained in the present study and a collection of human and animal reference sequences. As genotyping solely on the basis of the hypervariable regions of the hexon gene, as in our previous study, could miss important genetic differences between strains (Gray et al., 2007) , we also analysed the fiber gene. We looked at the distribution of different HAdV species and the possible presence of newly emerging types or naturally occurring recombinant strains.
RESULTS
The degenerate primers targeting the hexon gene (described in Supplementary Table S1, available in JGV Online) were able to amplify not only all HAdV reference strains, including the newly discovered HAdV-52, but also both canine (types 1 and 2) and one (type 1) of two bovine AdV strains tested. Negative controls yielded the expected results.
All clinical specimens analysed tested positive, yielding amplicons of different lengths, depending on the species present in each sample. A BLAST analysis of the sequences obtained identified seven different types, belonging to species C (83.2 % of samples), B (9.6 %) and F (7.2 %). The degree of nucleotide sequence identity with GenBank sequences was high (.98 %). Specifically, we found four types belonging to species C (serotype 1, 7.1 %; serotype 2, 66.6 %; serotype 5, 7.1 %; serotype 6, 2.4 %), two belonging to species B (serotype 3, 7.2 %; serotype 7, 2.4 %) and one belonging to species F (serotype 41, 7.2 %). No strains belonging to species A, D, E or G were detected.
High-quality sequence data were obtained from all but one of the 42 tested samples, indicating the presence of multiple genomes in the sample in question. The PCR product obtained from this sample was cloned as described below. Two genetic profiles emerged, strictly related to types 2 and 6, both belonging to species C.
The phylogenetic tree shown in Fig. 1 includes the strains sequenced in this work: field samples, reference clinical strains, HAdV-40 and -41 from ATCC, HAdV-52 and three animal AdVs (canine types 1 and 2, and bovine type 1). The tree also includes prototype sequences obtained from GenBank: J01917 (HAdV-2), AF534906 (HAdV-1), X67710 (HAdV-6), AY339865 (HAdV-5), AY594256 (HAdV-7) and DQ086466 (HAdV-3). Clinical samples formed wellsupported monophyletic groups and were represented with their corresponding prototype strains within each species. Our samples (in bold) were grouped into three main clusters, corresponding to species C, B and F. Species C was further subdivided into four groups, corresponding to types 1 (three samples), 2 (28 samples), 5 (four samples) and 6 (one sample).
Genetic variability within each subcluster, assessed through the computation of pairwise distances, was as follows: the mean distance between type 1 sequences (number of base substitutions per site) was 0.003, the distance between type 2 sequences was 0.007 and that between type 5 sequences was 0.003. Species B was divided into two subclusters, corresponding to type 3 (three samples, mean distance 0.001) and type 7 (a single sample). The F group contained three identical type 41 sequences.
The mean distance between animal and human sequences was 0.410 base substitutions per site for canine and 0.433 for bovine AdVs.
Clinical samples collected in the current study were further analysed for the fiber gene, using the species-specific primers described in Supplementary Table S1 . DNAs extracted from these samples were all successfully amplified, producing PCR amplicon lengths consistent with expectations. Here, too, nucleotide sequence identity with GenBank prototypes was high (.98 %). Generally speaking, the extent of genetic variability observed in the fiber gene was higher than that observed in the hexon gene: even among strains with identical hexon gene sequences, heterogeneous fiber gene sequences were found. The fiber gene BLAST analysis was concordant with the hexon analysis for all samples with the exception of sample 1446; this sample gave the highest degree of identity (100 %) with a HAdV-2 sequence in GenBank in the hexon gene, and with a HAdV-1 (99 %) sequence in the fiber gene. The phylogenetic tree constructed in the fiber region for species C (Fig. 2) showed that clinical samples formed wellsupported monophyletic clusters, similar to the hexon gene, with four groups corresponding to serotypes 1, 2, 5 and 6. Here, sample 1446 (marked with an *) grouped with the HAdV-1 cluster, as per BLAST typing. Further experiments aimed at ascertaining whether this sample was infected with a recombinant strain having a type 2-like hexon gene and a type 1-like fiber gene showed this not to be the case. Rather, this sample was co-infected with two different strains: a type 1 and a type 2 strain. Recombination Detection Program (RDP) analysis revealed no recombination events in either the hexon or the fiber genes.
DISCUSSION
HAdVs of any species may cause life-threatening infections in immunocompromised as well as in healthy individuals (Adeyemi et al., 2008; Fabbiani et al., 2009; Hoffman, 2009; Pham et al., 2003) . The species of the pathogen is among the variables associated with the clinical outcome of HAdV infection: HAdV species B1 (HAdV-B1), HAdV-C and -E tend to cause respiratory diseases, HAdV-B, -D and -E can cause eye disease, HAdV-F often causes gastroenteritis and HAdV-B2 tends to infect the kidneys and urinary tract as well as the respiratory system (Russell, 2009 ).
In the present study, specimens collected from patients seeking medical care at the A. Gemelli Hospital (Catholic University Medical School of Rome, Italy) were tested for HAdV by PCR assay systems targeting the hexon and fiber genes. In recent years, the introduction of PCR-based assays has enabled rapid, specific and sensitive AdV detection. Indeed, the International Committee on Taxonomy of Viruses has recently included phylogenetic analysis as a criterion for the definition of HAdV species (Benkö et al., 2005) . Specifically, phylogenetic analyses based on partial hexon sequences have been demonstrated as capable of distinguishing among prototype strains of HAdV (Lu & Erdman, 2006; Sarantis et al., 2004; Shimada et al., 2004) . The hexon is the major AdV capsid protein. Up to nine hypervariable regions are present in each hexon molecule (Russell, 2009) , which carries the most important epitopes for immune recognition and displays significant differences between HAdV serotypes (Ebner et al., 2005 (Ebner et al., , 2006 . The broad-range primer pair used in this study, encompassing the hypervariable region (HVR126) of loop 1 of the hexon gene, has been found previously to be capable of amplifying the genomes of all known HAdVs (Lu & Erdman, 2006) .
In agreement with the above finding, this assay allowed the detection of the entire spectrum of HAdVs included in the present study (field samples as well as reference strains, including the newly discovered type 52 of HAdV species G), suggesting that this PCR method may also be suitable for the detection of newly emerging strains.
Interestingly, despite the considerable genetic distance observed here between human and animal AdV strains, the region targeted by the degenerate primer pair in the hexon gene is so highly conserved that the primersspecifically designed to detect human strains -also identified both canine (types 1 and 2) and bovine (only type 1) AdVs. To the best of our knowledge, this is the first time a molecular AdV assay has been reported to allow such broad-range detection of the virus. This finding could have important implications for the interpretation of AdV detection data obtained with this broad-range assay in environmental samples, such as surface water, where both human and animal strains may occur. In such contexts, additional methods of typing may be required (e.g. sequencing) to help distinguish animal from HAdV amplicons.
Both the hexon and the fiber genes are considered 'hot spots' for base mutations and recombination, which are important driving forces for AdV serotype evolution (Darr et al., 2009; Kajon et al., 2010a; Lukashev et al., 2008; Yang et al., 2009) . Together with the hexon protein, the fiber protein, which enables the virus to attach to the cellular receptor, is responsible for the serotype specificity of AdV strains. As genotyping based only on the hypervariable regions of the hexon gene could miss important genetic differences between strains (Gray et al., 2007) , we included an analysis of the fiber gene as well. Generally speaking, the fiber gene exhibited greater genetic variability than the hexon gene. With the exception of one sample, typing based on the fiber and hexon analyses was in agreement. The sample in question showed a type 2-like hexon gene and a type 1-like fiber gene, and was collected from a 3-year-old child hospitalized with symptoms of diarrhoea, vomiting, fever and aphthous lesions on the tongue. To determine whether this was a case of co-infection or of an infection with a single recombinant strain (and to detect the crossingover point), we amplified the entire fragment between the hexon and fiber genes (six overlapping fragments of 2000 bp each, giving a total of~12 000 bp), cloned the PCR products and sequenced the different clones. The sample turned out to have been co-infected with two different strains: a type 1 and a type 2 strain. The coinfection was not initially detected, as sequencing for both the hexon and the fiber gene gave good-quality sequences (no overlapping electropherograms). This could have been the result of differential amplification of the different strains by the hexon and fiber primers. Another case of co-infection was detected (types 2 and 6), but in this case, direct sequencing of PCR products in the hexon gene immediately revealed the presence of multiple strains (mixed DNA sequence electropherograms). Clinical information concerning this last case of co-infection was scarce, with only two symptoms reported: fever and hypertransaminasaemia of unknown aetiology. Co-infections are significant in that they are a necessary condition for recombination events.
In our collection of clinical isolates, species C was the most prevalent species of HAdV detected, accounting for 83.2 % of positive samples, followed by species B and F. Within species C, HAdV type 2 made up 65 % of all isolates. Species C, including serotypes 1, 2, 5 and 6, is known to infect more than 80 % of the human population early in life and to cause about 5 % of symptomatic upper respiratory tract and 15 % of lower respiratory tract infections in children younger than 5 years (Garnett et al., 2002) . HAdV-C serotypes are also associated with a wide range of illnesses in immunocompromised patients, as well as, albeit less frequently, in healthy adults (Schmitz et al., 1983; Sivan et al., 2007) , and are well-known aetiological agents of nosocomial infections.
The second most frequent HAdV species was species B. This species is subdivided into two subspecies: B1 (types 3, 7, 16, 21 and 50) and B2 (types 11, 14, 34 and 35). Most of these serotypes cause respiratory and eye infections and have been associated with large outbreaks affecting both adults and children (Kajon et al., 1996; Ryan et al., 2002) such as pharyngoconjunctival fever and swimming poolrelated conjunctivitis outbreaks (Mena & Gerba, 2009; Segerman et al., 2003) . Outbreaks of serotypes 3 and 7 have been documented worldwide (Cooper et al., 2000; Hong et al., 2001; Kajon et al., 1999; Kim et al., 2003; Li et al., 1996) . For HAdV-3, a type characterized by considerable genetic diversity, new variants have been described associated with outbreaks of particularly severe disease (Kim et al., 2003; Lebeck et al., 2009; Metzgar et al., 2007) . Serotypes 3 and 7, along with 4, are known to be associated with acute respiratory disease in military recruits and, less frequently, in the civilian population (Metzgar et al., 2007) .
Species F (serotypes 40 and 41) is often associated with diarrhoea, mostly in children under 3 years of age (de Jong et al., 1993) . These viruses, commonly referred to as 'enteric AdVs', have nevertheless been detected in respiratory specimens as well (Echavarria et al., 2006) . In this survey, species F was detected in four (7.2 %) of our samples, all type 41.
We found no HAdVs belonging to species A, D, E or G. These species are also generally less frequently reported in epidemiological studies.
For the pathogenetic characteristics associated with the HAdV infections studied, the most common presenting manifestations were fever and gastrointestinal symptoms (diarrhoea and/or vomiting). Other symptoms included dizziness, drowsiness, exanthema, convulsion, arthralgia, asthenia, bilateral conjunctivitis and neurological signs, i.e. facial nerve deficit and coma. The different types were not significantly dissimilar with regard to the underlying disease: specific types were found to be able to cause a range of clinical manifestations. In general, types 2 and 41 were mainly associated with gastrointestinal symptoms (fever, vomiting and diarrhoea). Type 1 was observed in patients with the most severe symptomatology, including neurological impairment (high fever, dizziness, drowsiness and coma).
Six of the 42 infected patients were immunocompromised and thus especially susceptible to severe complications. Two cases of mortality occurred in these patients, both infected with type 2. The vast majority of patients (67 %) were very young (2-7 years). Duration of hospitalization was available for only 13 patients and ranged between 2 and 9 days (median 5.4 days).
Throat swab specimens resulted mainly in the recovery of type 2 (11/13), whilst faecal samples were positive for different HAdV types, including 1, 2, 3, 5 and 41. These findings are in agreement with other studies, indicating that virtually all HAdV types are shed in faeces (Akhter et al., 1995; Bányai et al., 2009; Bryden et al., 1993) .
The economic impact of HAdV infections, a common cause of respiratory disease and gastroenteritis, has been described as 'not negligible' (Mena & Gerba, 2009 ). Costs, including direct medical costs and indirect costs due to work absenteeism, were assessed in different populations (e.g. military recruits) and for different clinical manifestations (e.g. acute respiratory infections and outbreak of conjunctivitis) (Hyer et al., 2000; Piednoir et al., 2002) .
The seasonality of HAdV is not fully understood. In our study, the number of HAdV infections was higher in winter and spring, peaking in March. This pattern is in agreement with some, but not all, studies on the seasonality of the virus. In fact, other studies, including long-term investigations, have reported no seasonal pattern (Carraturo et al., 2008; Schmitz et al., 1983; Wong et al., 2008) .
In summary, our results confirmed species C, and particularly serotype 2 of this species, as one of the most frequently isolated HAdV from hospitalized patients in Italy. Overall, seven types belonging to three species (B, C and F) were identified, as well as two co-infections, each with two serotypes within species C (types 1/2 and 2/6).
The originality of this study lies in the parallel analysis of two different genome regions potentially able to detect recombinant sequences. The combined use of the two PCR assays proposed here -one of which was designed in the framework of the present study -allows the identification of known strains and the detection of newly emerging types. This methodology, thus, can provide valuable Viruses from clinical samples were grown in Hep-2, Vero and MRC5 cells. Infected cell cultures were tested with specific fluorescent antibodies to confirm the presence of HAdV. Viral genomes were extracted from 140 ml infected cell lysate using a QIAamp Viral RNA Mini kit (Qiagen) according to the manufacturer's instructions. Nucleic acids were resuspended in 60 ml elution buffer, aliquotted into small volumes and stored at 280 uC until use.
PCR and sequencing. We used a molecular typing assay based on PCR amplification and sequencing of portions of the AdV hexon and fiber genes, with both published and newly designed primers. First, a portion of the hexon gene was amplified using the degenerate primer pair described by Lu & Erdman (2006) , slightly modified from the pair previously published by Crawford-Miksza & Schnurr (1996) to accommodate newly available sequence data. These primers encompassed the hypervariable regions HVR126 of loop 1 of the hexon gene and yielded PCR products ranging in size from 764 to 896 bp depending on serotype and species. For amplification of partial fiber gene sequences, we engineered new primers based on the conserved regions of this gene in the six HAdV species A-F. This was done by analysis of available sequences in GenBank using Primer3 software, version 0.4.0 (http://frodo.wi.mit.edu/primer3/) (Rozen & Skaletsky, 2000) . Supplementary Table S1 shows the primers used and PCR IDs, along with amplicon lengths. Each sample, primer and PCR was assigned a code (ID) in our SQL database.
PCR amplification was performed in a 25 ml reaction volume containing 12.5 ml GoTaq Green Master Mix (Promega), 1 ml each primer (22 pmol ml 21 ) and 1 ml nucleic acid extract. A GeneAmp PCR System 9700 (Applied Biosystems) was used with the following settings: denaturation at 94 uC for 4 min, followed by 35 cycles of 94 uC for 1 min, 54 uC for 1 min and 72 uC for 1 min, with a final extension cycle at 72 uC for 10 min. Standard precautions were taken to prevent PCR contamination.
Amplified products were separated on a 1 % agarose gel stained with ethidium bromide. Following amplification, PCR products were purified using a Montage PCRm96 Micro-well Filter Plate (Millipore). Bidirectional sequencing was performed using the above-mentioned amplification primers and an ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction kit version 3.1. Unincorporated dye terminators were removed using a Montage SEQ96 Sequencing Reaction Cleanup kit (Millipore). Sequencing analysis was performed on a single-capillary sequencer (ABI 310 DNA Sequencer; Applied Biosystems).
Cloning of PCR products. In one sample, direct sequencing yielded multiple sequences. The PCR product was therefore cloned into the PCR4-TOPO vector (Invitrogen) using the TA cloning strategy, following the manufacturer's protocol. Recombinant plasmids, obtained from eight different clones, were purified using a Plasmid Mini kit (Qiagen) and sequenced using vector-specific primers (M13 forward and M13 reverse). For another sample, showing a type 2-like hexon gene and a type 1-like fiber gene, the entire region between the hexon and fiber genes was amplified (six overlapping fragments of 2000 bp each, giving a total of~12 000 bp) using newly designed primers able to detect types 1 and 2 (data not shown). The PCR products were cloned and sequenced as described above.
Bioinformatic analysis. All sequences were submitted to BLAST analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi/) to identify their most closely related matches in public databases. Bioinformatic analysis was performed as follows: the raw forward and reverse ABI files were aligned and assembled into a single consensus sequence using MEGA software version 4.0 (Tamura et al., 2007) . Phylogenetic analysis was performed using the same program. The robustness of the clustering results was assessed by bootstrap resampling (1000 replicates). For genetic distance calculations and pairwise distance comparisons, Kimura's two-parameter model was used, integrated into the MEGA software.
Consensus sequences were submitted to the EMBL Nucleotide Sequence Database using the Webin tool available at http://www. ebi.ac.uk/embl/Submission/. Recombination signals in this set of aligned sequences were analysed using RDP version 3, available at http://darwin.uvigo.es/rdp/rdp.html (Martin et al., 2005) . This tool identifies possible breakpoint sites using six statistical analytical methods (RDP, Geneconv, BOOTSCAN, maximum x 2 , Chimaera and sister scanning analyses).
